Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 3.

Hillmen, Peter, Brown, Jennifer R., Eichhorst, Barbara F., Lamanna, Nicole ORCID: 0000-0003-3331-9491, O'Brien, Susan M., Qiu, Lugui, Salmi, Tommi, Hilger, James, Wu, Kenneth, Cohen, Aileen, Huang, Jane and Tam, Constantine S. (2020). ALPINE: zanubrutinib versus ibrutinib in relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma. Future Oncol., 16 (10). S. 517 - 524. LONDON: FUTURE MEDICINE LTD. ISSN 1744-8301

Salles, Gilles A., Boyd, Thomas E., Morschhauser, Franck, Wendtner, Clemens-Martin, Hallek, Michael, Eichhorst, Barbara F., Kozloff, Mark, Cartron, Guillaume, Li, Yan, Hilger, James, Mobasher, Mehrdad and Stilgenbauer, Stephan (2015). Updated Safety and Preliminary Efficacy Data from a Phase 1b Study Combining Venetoclax (GDC-0199, ABT-199) with Bendamustine/Rituximab in Patients with Relapsed/Refractory or Previously Untreated Chronic Lymphocytic Leukemia. Blood, 126 (23). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Stilgenbauer, Stephan, Morschhauser, Franck, Wendtner, Clemens-Martin, Cartron, Guillaume, Hallek, Michael, Eichhorst, Barbara F., Kozloff, Mark, Giever, Thomas A., Lozanski, Gerard, Punnoose, Elizabeth A., Wang, Jue, Hilger, James, Mobasher, Mehrdad and Salles, Gilles (2016). Phase Ib Study (GO28440) of Venetoclax with Bendamustine/Rituximab or Bendamustine/Obinutuzumab in Patients with Relapsed/ Refractory or Previously Untreated Chronic Lymphocytic Leukemia. Blood, 128 (22). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

This list was generated on Thu Mar 28 17:53:24 2024 CET.